All Thumbs Up From FDA Panel for Bacterial Pneumonia Therapy

(MedPage Today) -- An FDA advisory panel voted unanimously in favor of recommending that the FDA approve sulbactam-durlobactam for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by...
Source: MedPage Today Public Health - Category: American Health Source Type: news